Article Sidebar

PDF (Tiếng Việt)
Published: 2023-10-30
Abstract Views: 393
Views PDF (Tiếng Việt): 408
DOI: https://doi.org/10.52852/tcncyh.v170i9.1940
Issue
Vol. 170 No. 9 (2023)
Section
Các bài báo
How to Cite
Tuyết, T. T., Hiếu, V. N., & Châu, T. M. (2023). 25. Antibiotic resistance and correlation with virulence factor of helicobacter pylori at Hanoi Medical University Hospital 2019-2022. Journal of Medical Research, 170(9), 228-238. https://doi.org/10.52852/tcncyh.v170i9.1940

25. Antibiotic resistance and correlation with virulence factor of helicobacter pylori at Hanoi Medical University Hospital 2019-2022

Tran Thi Tuyet, Vu Ngoc Hieu, Tran Minh Chau

Main Article Content

Abstract

Antibiotics-resistance prevalence of H. pylori is increasing which results in difficulties in eradication of H. pylori – the leading cause to the development of gastric cancer. The purpose of this study was to evaluate the current antibiotic susceptibility of H. pylori at Hanoi Medical University Hospital from 2019 to 2023. Susceptibility testing was conducted by the Epsilometer test (E-test) method for ampicillin, clarithromycin, levofloxacin, metronidazole and tetracycline. Of the 729 biopsy samples, H. pylori was successfully cultured from 392 samples (53.7%). The isolates were tested for antibiotic susceptibility and stored at -70˚C Utra-low temperature freezer. There were 224 strains recovered by subculturing from strains that were stored at -70˚C Utra-low temperature freezer. PCR was performed on the DNA extracted from these strains for the determination of virulence factor (cagE, vacAs, vacAm, iceA1, homB). The percentage of H. pylori resistance to AMX was 67%, to CLR was 96.2%, to LVX and TE were 46% and 0.5%, respectively. Meanwhile, 100% of strains are sensitive to MTZ. The positive rates for the cagE, vacAs, vacAm, iceA1, homB genes in H. pylori were 71%; 93,3%; 69.2%; 21%; and 34.3%. A significant relationship was observed between amoxicillin resistant rate with homB(+) or cagE-homB(+) (p < 0.05).

Article Details

Keywords

Helicobacter pylori, antibiotic resistance, virulence factor

References

1. Hooi JKY, Lai WY, Ng WK, et al. Global Prevalence of Helicobacter pylori Infection: Systematic Review and Meta-Analysis. Gastroenterology. 2017; 153(2): 420-429. doi:10.1053/j.gastro.2017.04.022.
2. Dao LV, Dao HV, Nguyen HT, et al. Helicobacter pylori infection and eradication outcomes among Vietnamese patients in the same households: Findings from a non-randomized study. PLoS One. 2021; 16(11): e0260454. doi:10.1371/journal.pone.0260454.
3. Yamaoka Y. How to eliminate gastric cancer-related death worldwide? Nat Rev Clin Oncol. 2018; 15(7): 407-408. doi:10.1038/s41571-018-0029-8.
4. Lee YC, Chiang TH, Chou CK, et al. Association Between Helicobacter pylori Eradication and Gastric Cancer Incidence: A Systematic Review and Meta-analysis. Gastroenterology. 2016; 150(5): 1113-1124.e5. doi:10.1053/j.gastro.2016.01.028.
5. Karbalaei M, Talebi Bezmin Abadi A, Keikha M. Clinical relevance of the cagA and vacA s1m1 status and antibiotic resistance in Helicobacter pylori: a systematic review and meta-analysis. BMC Infect Dis. 2022; 22:573. doi:10.1186/s12879-022-07546-5.
6. R M, Sb M, Mds M, Af DS, K I, Fj C. Helicobacter pylori cag pathogenicity island genes: clinical relevance for peptic ulcer disease development in Brazil. Journal of medical microbiology. 2007; 56(Pt 1). doi:10.1099/jmm.0.46824-0.
7. Shetty V, Lingadakai R, Pai GC, Ballal M. Profile of Helicobacter pylori cagA &vacA genotypes and its association with the spectrum of gastroduodenal disease. Indian J Med Microbiol. 2021; 39(4): 495-499. doi:10.1016/j.ijmmb.2021.06.001.
8. Jung SW, Sugimoto M, Graham DY, Yamaoka Y. homB status of Helicobacter pylori as a novel marker to distinguish gastric cancer from duodenal ulcer. J Clin Microbiol. 2009; 47(10): 3241-3245. doi:10.1128/JCM.00293-09.
9. Haddadi MH, Negahdari B, Asadolahi R, Bazargani A. Helicobacter pylori antibiotic resistance and correlation with cagA motifs and homB gene. Postgrad Med. 2020; 132(6): 512-520. doi:10.1080/00325481.2020.1753406.
10. Nguyen TC, Le GKN, Pham DTH, et al. Antibiotic resistance and heteroresistance in Helicobacter pylori isolates from symptomatic Vietnamese children: A prospective multicenter study. Helicobacter. 2023; 28(5): e13009. doi:10.1111/hel.13009.
11. Đặng Ngọc Quý Huệ (2018). Nghiên cứu tỉ lệ kháng Clarithromycin, Levofloxacin của Helicobacter Pylori bằng Epsilometer và hiệu quả của phác đồ EBMT ở bệnh nhân viêm dạ dày mạn,.
12. Trần Thị Như Lê (2023). Tổng quan nghiên cứu: Đặc điểm kháng levofloxacin về kiểu hình và kiểu gen của Helicobacter pylori giai đoạn 2012 - 2022. Tạp chí nghiên cứu Y học Đại học Y Hà Nội, 160,1-11.
13. Nguyễn Thị Chi (2020). Nghiên cứu kháng kháng sinh và đánh giá hiệu quả tiệt trừ Helicobacter pylori dựa trên kháng sinh đồ.
14. Etest application guide.
15. Roberts LT, Issa PP, Sinnathamby ES, et al. Helicobacter Pylori: A Review of Current Treatment Options in Clinical Practice. Life. 2022; 12(12): 2038. doi:10.3390/life12122038.
16. Đào Việt Hằng và cộng sự (2020). Kết quả điều trị diệt trừ Helicobacter pylori của phác đồ nối tiếp 4 thuốc có Bismuth trong các hộ gia đình.Tạp chí Nghiên cứu Y học,128,113-121
17. Tran TT, Nguyen AT, Quach DT, et al. Emergence of amoxicillin resistance and identification of novel mutations of the pbp1A gene in Helicobacter pylori in Vietnam. BMC Microbiol. 2022; 22(1): 41. doi:10.1186/s12866-022-02463-8.
18. Savoldi A, Carrara E, Graham DY, Conti M, Tacconelli E. Prevalence of Antibiotic Resistance in Helicobacter pylori: A Systematic Review and Meta-analysis in World Health Organization Regions. Gastroenterology. 2018; 155(5): 1372-1382.e17. doi:10.1053/j.gastro.2018.07.007.
19. Salvo F, De Sarro A, Caputi AP, Polimeni G. Amoxicillin and amoxicillin plus clavulanate: a safety review. Expert Opin Drug Saf. 2009; 8(1): 111-118. doi:10.1517/14740330802527984.
20. Phân tích thực trạng sử dụng kháng sinh và kháng kháng sinh ở Việt Nam.
21. Qiao W, Hu JL, Xiao B, et al. cagA and vacA genotype of Helicobacter pylori associated with gastric diseases in Xi’an area. World J Gastroenterol. 2003; 9(8): 1762-1766. doi:10.3748/wjg.v9.i8.1762.
22. Chomvarin C, Namwat W, Chaicumpar K, et al. Prevalence of Helicobacter pylori vacA, cagA, cagE, iceA and babA2 genotypes in Thai dyspeptic patients. Int J Infect Dis. 2008; 12(1): 30-36. doi:10.1016/j.ijid.2007.03.012.
23. Peek RM, Thompson SA, Donahue JP, et al. Adherence to gastric epithelial cells induces expression of a Helicobacter pylori gene, iceA, that is associated with clinical outcome. Proc Assoc Am Physicians. 1998; 110(6): 531-544.
24. Oleastro M, Cordeiro R, Ferrand J, et al. Evaluation of the clinical significance of homB, a novel candidate marker of Helicobacter pylori strains associated with peptic ulcer disease. J Infect Dis. 2008; 198(9): 1379-1387. doi:10.1086/592166.
25. ArsRS-Dependent Regulation of homB Contributes to Helicobacter pylori Biofilm Formation - PubMed. Accessed August 27, 2023. https://pubmed.ncbi.nlm.nih.gov/30116222/.
26. Wong EHJ, Ng CG, Chua EG, et al. Comparative Genomics Revealed Multiple Helicobacter pylori Genes Associated with Biofilm Formation In Vitro. PLoS One. 2016; 11(11): e0166835. doi:10.1371/journal.pone.0166835.
27. Haddadi MH, Negahdari B, Asadolahi R, Bazargani A. Helicobacter pylori antibiotic resistance and correlation with cagA motifs and homB gene. Postgraduate Medicine. 2020; 132(6): 512-520. doi:10.1080/00325481.2020.1753406.